Inventor · disambiguated record
Nathan Guz
Also filed as: GUZ NATHAN
11 granted patents·4 pending applications·70 citations·filing 2015–2023
90Inventor score
Top patents by PatentIndex Score
15 records- 0195US11724986B2Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2020·Granted Aug 15, 2023·6 cites·4 claims
- 0294US10851061B2Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2019·Granted Dec 1, 2020·8 cites·8 claims
- 0394US10577345B2Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Mar 3, 2020·12 cites·17 claims
- 0494US10077249B2Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Sep 18, 2018·24 cites·36 claims
- 0592US11760726B2Crystalline solid forms of N-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl} -n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2021·Granted Sep 19, 2023·2 cites·11 claims
- 0692US10501418B2Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2015·Granted Dec 10, 2019·12 cites·11 claims
- 0783US10239858B2Process for making compounds for use in the treatment of cancerEXELIXIS INC·Filed 2017·Granted Mar 26, 2019·3 cites·7 claims
- 0882US9771347B2Process for making compounds for use in the treatment of cancerEXELIXIS INC·Filed 2015·Granted Sep 26, 2017·3 cites·2 claims
- 0981US12486233B2Crystalline Solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2023·Granted Dec 2, 2025·0 cites·11 claims
- 1077US2022135533A1Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1176US2023219922A1Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1274US2021284623A1Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehydeGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1371US11414396B2Process for making compounds for use in the treatment of cancerEXELIXIS INC·Filed 2020·Granted Aug 16, 2022·0 cites·8 claims
- 1468US10793541B2Process for making compounds for use in the treatment of cancerEXELIXIS INC·Filed 2019·Granted Oct 6, 2020·0 cites·6 claims
- 1553US2024043456A1Crystalline Solid Meglumine Salt Inhibitor of BCL and Methods of Making and Using SameUNITY BIOTECHNOLOGY INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →